The blood-brain barrier (BBB) and the environment of the central nervous system (CNS) guard the nervous tissue from peripheral immune cells. In the autoimmune disease multiple sclerosis, myelin-reactive T-cell blasts are thought to transgress the BBB 1, 2 and create a pro-inflammatory environment in the CNS, thereby making possible a second autoimmune attack that starts from the leptomeningeal vessels and progresses into the parenchyma [3] [4] [5] [6] . Using a Lewis rat model of experimental autoimmune encephalomyelitis, we show here that contrary to the expectations of this concept, T-cell blasts do not efficiently enter the CNS and are not required to prepare the BBB for immune-cell recruitment. Instead, intravenously transferred T-cell blasts gain the capacity to enter the CNS after residing transiently within the lung tissues. Inside the lung tissues, they move along and within the airways to bronchus-associated lymphoid tissues and lung-draining mediastinal lymph nodes before they enter the blood circulation from where they reach the CNS. Effector T cells transferred directly into the airways showed a similar migratory pattern and retained their full pathogenicity. On their way the T cells fundamentally reprogrammed their gene-expression profile, characterized by downregulation of their activation program and upregulation of cellular locomotion molecules together with chemokine and adhesion receptors. The adhesion receptors include ninjurin 1, which participates in T-cell intravascular crawling on cerebral blood vessels. We detected that the lung constitutes a niche not only for activated T cells but also for resting myelin-reactive memory T cells. After local stimulation in the lung, these cells strongly proliferate and, after assuming migratory properties, enter the CNS and induce paralytic disease. The lung could therefore contribute to the activation of potentially autoaggressive T cells and their transition to a migratory mode as a prerequisite to entering their target tissues and inducing autoimmune disease.
We monitored the invasion of the CNS by green-fluorescentprotein (GFP)-expressing myelin basic protein (MBP)-reactive T cells (T MBP-GFP cells) 7 over the preclinical phase of Lewis rat transfer experimental autoimmune encephalomyelitis (EAE). Only very few early invading pioneer T cells 1, 2 were detected in the CNS in the first 60 h after intravenous transfer of activated T MBP-GFP cells (,100 T cells per total spinal cord). The bulk of T MBP-GFP cells (. 10 6 T cells per total spinal cord) started to invade the CNS at the leptomeningeal vessels of the spinal cord 60-84 h after T-cell transfer, shortly before the onset of clinical symptoms ( Fig. 1a and Supplementary Fig. 1a , b) 3, 4, 8 . Pro-inflammatory cytokines and adhesion molecules in the CNS became detectable only during the mass T-cell invasion (Supplementary Fig. 1c ) 3, 9 .
The T MBP-GFP cells nearly all disappeared from the blood almost immediately after intravenous infusion. It was not until 48 h later that a gradual increase of T MBP-GFP cells was observed in the blood and spleen, closely followed by the start of the main invasion of the T cells into the CNS (Fig. 1b) . This coincidence of the reappearance of the T MBP-GFP cells in blood and spleen and their invasion into the CNS led us to test whether the re-emerged cells (termed T migratory cells) would enter the nervous tissue more efficiently than the initially transferred T MBP-GFP cell blasts (T blast cells). To do this, we prepared an anastomosis between the blood circulations of two animals, one of which had received T blast cells 48 h beforehand (pre-EAE animal) and the other was a naïve rat that was not pre-treated (Supplementary Fig. 2a) . Interestingly, T MBP-GFP cells passing through the blood shunt within 12 h after anastomosis infiltrated the CNS of the animal that was not pre-treated in similar frequencies to those of the pre-EAE animal (Fig. 1c) . Furthermore, in contrast to T blast cells, T migratory cells isolated from the spleen (60 h after T-cell transfer) readily immigrated into the inflamed CNS and, more importantly, into the CNS of animals that were not pre-treated ( Fig. 1d and Supplementary Fig. 2b-e) . Intravital two-photon microscopy revealed that T migratory cells were crawling on the meningeal vessels within minutes after intravenous transfer. Twenty-four hours later, the T migratory cells had transgressed the vessel walls and were moving throughout the leptomeningeal surface and deep within the CNS parenchyma, like T cells usually do 3 to 4 days after transfer of T blast cells ( Supplementary Fig. 2e -h and Supplementary Movie 1) 6, 10 . T migratory cells in the CNS upregulated interleukin-2 (IL-2) receptor, OX40, interferon-c (IFN-c) and IL-17, indicative of a recent antigen encounter and reactivation within the CNS, the trigger for generalized parenchymal inflammation and disease ( Supplementary Fig. 2i-k) 3, 4, 6, 11 . Beginning 24 h after T-cell transfer the animals developed the first clinical signs of weight loss, followed 24 h later by overt paralytic disease; approximately 48 h earlier than in the typical transfer EAE (Supplementary Fig. 2l ).
To identify the homing niches of T blast cells after intravenous transfer, we analysed whole body sections of animals, complemented by cytofluorometric cell quantifications. At the early time points, almost all of the T blast cells were located in the lung (Fig. 2a and Supplementary Fig. 3a, b) . Some cells were also found distributed in the mucosa of the small intestine. Thereafter, T MBP-GFP cells accumulated in lungdraining mediastinal lymph nodes, before they appeared in the blood and spleen (Fig. 1b and Supplementary Fig. 3c ). Notably, T MBP-GFP cells extracted from the lung at 48 h after transfer and injected into naïve recipient rats accumulated in the CNS within 24 h, where they displayed signs of activation ( Fig. 2b and Supplementary Fig. 3d) . Thus, the cells became competent in the lung to enter and to get reactivated within the CNS. This led us to analyse T MBP-GFP cell behaviour within the lung in more detail. Within the first 12 h after transfer, T blast cells were distributed within the peripheral lung parenchyma. Then 24-48 h after transfer, they moved along bronchial structures and accumulated in areas consisting of densely packed clusters of lymphocytes; that is, bronchus-associated lymphoid tissues (BALT) (Fig. 2c, Supplementary Fig. 3e and Supplementary Movie 2). Interestingly, T MBP-GFP cells significantly increased their velocity during their journey (from 3.7 mm min 21 to 5.2 mm min
21
) and at the same time the percentage of arrested cells decreased (from 75% to 50%) ( 
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although this transepithelial migratory path into the airways has been considered to be a dead end for the cells 12 . Therefore, to test whether T cells can pass through the airways, we transferred T blast cells intratracheally. Similarly to intravenously transferred cells, intratracheally transferred T cells migrated along the airways and maintained their capacity to emigrate out of the lung and to induce clinical disease ( Supplementary Fig. 3i ).
The homing of effector T cells to the lung is not an artefact of transfer EAE. T MBP-GFP cells also accumulated in the lung after 'classical' antigenic stimulation in peripheral lymph nodes after subcutaneous immunization ( Supplementary Fig. 4a ). Moreover, memory T MBP-GFP cells, which had been embedded in the rat immune system over months, were also found to home and persist within the lung ( Supplementary Fig. 4b ). Importantly, these cells could readily be activated to become pathogenic: after intratracheal immunization with MBP the cells developed strong signs of activation and, after vigorous amplification within the lung and its draining lymph nodes, they moved into the blood and spleen from where they reached the CNS and triggered a paralytic disease (Fig. 2f, g and Supplementary  Fig. 4b-e) . Notably, this lung-derived autoimmune response did not differ from the one after stimulation of the memory T cells in the lymph nodes (Fig. 2f , g and Supplementary Fig. 4c -e). The stimulatory potential of the lung environment was confirmed further by local activation of resting T MBP-GFP cells that had been inserted into the lung by intratracheal transfer. Again, similarly to the stimulation in lymph nodes, the T cells in the lung underwent effective activation and proliferation following intratracheal administration of antigen, and they gained the capacity to invade the CNS and to evoke clinical EAE ( Fig. 2h and Supplementary Fig. 4f-h ).
Interestingly, T MBP-GFP cells changed their reactivity for chemotactic stimuli during the preclinical phase of transfer EAE. Early ex-vivoisolated T MBP-GFP cells (5 min and 24 h after T-cell transfer) predominantly migrated towards the homeostatic chemokines CCL19 and CCL21 (Fig. 3a) . These migratory preferences of the cells coincided with their migration to bronchial structures and the BALT that express CCL19 and CCL21 ( Supplementary Fig. 5a ) 13 . Pertussis toxin (PTX), which irreversibly blocks chemokine signalling 14 , significantly reduced their accumulation within the BALT ( Supplementary Fig. 5b ), supporting the view that the T-cell migration to the bronchial structures and BALT was driven by CCL19 and CCL21. However, PTX pre-treatment did not interfere with the homing of the T cells to the lung and, in contrast to earlier reports about the effect of PTX on T-cell motility in lymph nodes 15 , did not change their locomotion activities (Supplementary Fig. 5c ). From 48 h after transfer onwards, T MBP-GFP cells responded mainly to gradients of inflammatory chemokines, such as CXCL11 and CCL5 (Fig. 3a) . This 're-orientation' of the cells was relevant to their ability to home to their target organ: interference with CXCR3 signalling, that is, the corresponding receptor of CXCL11, significantly reduced their CNS invasion and the severity of clinical EAE ( Supplementary Fig. 5d ). Notably, T MBP-GFP cells left the lung at least partially under the control of sphingolipid signalling. Treatment with FTY720, a receptor agonist that functionally interferes with sphingosine 1-phosphate receptors (S1P1) 16 , led to a substantial trapping of the T cells within the BALT, but did not hamper the entry of the cells into the lung or their locomotion behaviour there ( Supplementary Fig. 5e , f). FTY720 treatment significantly reduced the numbers of T MBP-GFP cells in the blood and CNS, and delayed and ameliorated clinical EAE ( Supplementary Fig. 5g, h ), which could well be explained by the arrest of the pathogenic T cells within the lung.
These results suggest that T MBP-GFP cells get equipped during their journey through peripheral environments to enter their target tissue. To characterize these functional changes in more detail, we analysed genome-wide transcriptional profiles of T blast cells (before intravenous transfer) and T migratory cells (isolated 3 days after T-cell transfer from the spleen) using Affymetrix 230.0 expression arrays. Average linkage cluster analysis (Genesis) revealed ,1800 upregulated and ,1600 downregulated transcripts (out of 30,248) for activated compared to migrating T MBP-GFP cells, respectively. These changes ($2-fold) could be grouped into two major gene clusters that included reciprocally Fold changes after the indicated treatment are shown on the y axis. Cumulative data from three independent experiments per treatment. *P , 0.05; **P , 0.01; ***P , 0.001. NS, not significant.
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regulated pathways (Fig. 3b) . In comparison to T blast cells, T migratory cells downregulated their immune activation and proliferation programs ( Supplementary Fig. 6a-d) ; that is, pro-inflammatory cytokines, costimulatory molecules, cell-cycle-associated genes, cyclin-dependent kinases and factors of the DNA replication machinery. By contrast, genes controlling cell motility and cell adhesion were strongly upregulated ( Supplementary Fig. 6e ). Accordingly, transcription factors that are important for regulating T-cell cycling and migration-for example, Klf2 (ref. 17)-were among the most upregulated genes in T migratory cells ( Fig. 3b and Supplementary Fig. 6c ).
To evaluate the functional relevance of the newly assumed adhesive profile, we tested ninjurin 1 (Ninj1), a two-pass transmembrane adhesion molecule that functions by homophilic binding. Ninj1 was recently found to be expressed in myeloid cells and CNS endothelia, and was upregulated during EAE ( Supplementary Fig. 7a-c ) [18] [19] [20] . We found Ninj1 expression and a transient upregulation in T migratory cells, but not in naïve T or B cells ( Supplementary Fig. 7b-d) . Intriguingly, intravenous infusion of Ninj1-blocking peptide (amino acids , that blocks homophilic Ninj1 binding, strongly reduced the numbers of T cells crawling on the intraluminal side of the CNS vessels (Fig. 3c,  d , Supplementary Fig. 7e and Supplementary Movie 5). This might explain the reduced T migratory cell entry into the CNS and the delayed and ameliorated disease course after intravenous infusion of the Ninj1-blocking peptide ( Supplementary Fig. 7f, g ). Overexpression of Ninj1 by retroviral gene transfer promoted the entry of T cells overexpressing GFP and Ninj1 (T MBP-GFP-Ninj1 cells) into the CNS and accelerated the onset of clinical EAE ( Supplementary Fig. 7h-j) . The integrin a 4 (very late antigen 4, VLA4), whose b1 chain was also upregulated in T migratory cells ( Supplementary Fig. 6e ), had similar effects on the intravascular T-cell motility as shown by blockage with VLA4-neutralizing antibody (Fig. 3d) . It is clear that both adhesion molecules have a role in T-cell crawling by strengthening the endothelial adherence of the cells. Interestingly, Ninj1 blockage was less efficient in interfering with the initial adhesion steps of the cells to the endothelia than the anti-VLA4 treatment ( Fig. 3d and Supplementary Fig. 7e) .
To explore the regulation dynamics of the migratory mode in T MBP-GFP cells in vivo, we analysed the expression profiles of a selected set of the regulated genes in T cells during their migratory paths. Our results show that the reprogramming process in T cells is already initiated in the lung, and is continued during their migration through the mediastinal lymph nodes and spleen ( Supplementary Fig. 8) .
Notably, the development of a migratory mode was not restricted to T cells during transfer EAE: memory or post-activated T MBP-GFP cells after intratracheal or subcutaneous immunizations assumed a very similar migratory mode before they accumulated at the CNS ( Supplementary Fig. 9a-f) . Furthermore, the observed homing patterns of intravenously transferred T-cell blasts and their switch to migration-competent effector cells were not restricted to T MBP cells, but were also seen in neuritogenic P2-reactive T cells or T cells recognizing ovalbumin (Fig. 4 and Supplementary Fig. 9g-k) . Our data show that the preclinical phase of transfer EAE cannot be explained solely by the integrity of the BBB or the immune hostile environment of the CNS having to be breached by activated 'pioneer' T cells 1,2 before the mass of the T cells get access into their target organ. The majority of the transferred cells during this phase of transfer EAE home to the peripheral environments of the lung from where they move to the BALT and draining lymph nodes, before they re-enter the blood circulation and finally reach the CNS. On their way, the T cells profoundly reprogram their gene-expression profile, and this includes upregulation of membrane receptors, such as the S1P1, that have a role in guiding the cells out of lymphatic structures 21 . Additionally, the T cells upregulate chemokine receptors and adhesion molecules that regulate their orientation towards inflamed tissues and simultaneously raise their capacity to transgress endothelial barriers, including those of CNS vessels [22] [23] [24] . At the same time, the T cells downregulate their proliferation and activation programs and thus prepare for antigen re-encounter and activation. A premature reactivation or hyper-reactivation would cripple the immune response by causing T-cell apoptosis or anergy 25, 26 . Importantly, the switch of activated autoaggressive T cells towards a migratory mode occurs before the onset of any deleterious inflammatory processes within the attacked organs. Several of the genes recently identified in genome-wide association studies as risk genes for the development of multiple sclerosis 27 were found in the fraction of regulated genes in our transcriptome analysis ( Supplementary Fig. 10) . Recently, the gut environment came into focus as a potential site for the initial priming of autoreactive T cells during spontaneous EAE 28 . We demonstrate here that the lung can serve as a location where autoreactive T cells become reactivated and gain the competence to enter the CNS. It is well known that relapses in multiple sclerosis are triggered by inflammations of the respiratory tract 29 . The lung is in constant and direct contact with the outer environment and is colonized by microbiota that can actively promote local immune responses 30 . This organ represents a homing place for effector and memory cells relevant to host defence and asthma pathogenesis. At the same time, the lung represents a niche for potentially autoaggressive effector and memory T cells. Our data indicate that stimulatory environmental factors might directly elicit a pathogenic response of these cells.
METHODS SUMMARY
CD4
1
CD8
2 abTCR 1 MBP-, ovalbumin-and P2-specific T cells retrovirally engineered to express enhanced GFP were established from lymph nodes of immunized Lewis rats as reported 7 . All cell lines were tested for cytokine profile, antigen specificity and surface phenotype. Memory animals were established by intraperitoneal transfer of T MBP-GFP cells into neonatal rats. If not otherwise stated, transfer EAE was induced by intravenous injection of 5 3 10 6 T blast cells or by intratracheal administration of 2 3 10 6 T blast cells. Active EAE was induced in memory animals by intratracheal or subcutaneous immunization. In naïve animals, aEAE was induced by subcutaneous or intratracheal transfer of resting T cells followed by immunization. Transfer of migration-competent T MBP-GFP cells into recipient animals, cross-circulation model and therapeutic interference are described in the Methods. Animal experiments were in compliance with regulations of the Bavarian and Lower Saxony state.
Time-lapse two-photon laser-scanning microscopy, fluorescence video microscopy time-lapse recordings and image analyses are described in Methods.
T MBP-GFP cells were isolated from the single organs as described 8 . Cell sorting was carried out using FACS Vantage, FACSAria (Becton Dickinson) or MoFlo (Beckman Coulter). Cytofluorometric analysis was performed with FACS-Calibur operated by Cell Quest software.
Total RNA was used to perform a genome-wide transcriptional profiling assay (Rat Genome 230, Affymetrix). Messenger RNA extraction, complementary DNA reversion and Taqman analyses are described in Methods.
Graphs were generated and statistical tests performed using Graphpad 5.0.4. Antigens. T-cell clones were specific for guinea-pig MBP, ovalbumin (OVA) and P2 peptide. MBP was isolated from guinea-pig brains as described 31 . OVA was from Sigma. The synthetic peptide of bovine P2 myelin protein (amino acids 53-78) was synthesized by the Max Planck Institute for Biochemistry. Generation and culturing of T cells. MBP-, OVA-and P2 CD4
1 T cells retrovirally engineered to express the enhanced GFPs (eGFPs) (T MBP-GFP , T OVA-GFP , T P2-GFP ) were generated as reported 7 . Ten days after subcutaneous immunization with MBP, OVA, P2 peptide in CFA (which was prepared by supplementing Incomplete Freund's Adjuvant (Difco Laboratories) with 2 mg ml 21 of inactivated Mycobacterium tuberculosis H37Ra (Difco Laboratories)), cells were collected from the draining lymph nodes and co-cultured in the presence of retrovirus-producing GP1E 86 packaging cells. Murine stem-cell virus (pMSCV, Invitrogen) in which the eGFP gene (Invitrogen) had been integrated (pMSCV-eGFP) was used as the retroviral vector. After 2 days of co-culture, T-lymphocyte blasts were expanded in IL-2-containing growth medium for 5 days and then re-stimulated in the presence of irradiated thymocytes pulsed with the specific antigen. Selection with G418 and amplification of the T cells was carried out as reported 32 . All the cell lines were CD4
1
, CD8
2 and abTCR
1
, and were extensively tested for their phenotype, cytokine profile and antigen specificity.
Memory animals were prepared as previously described . Experiments were performed in animals that were 10-14 weeks old. EAE models. For transfer, MBP-specific T GFP cells were stimulated as described above. Two days later, naïve Lewis rats (6-8 weeks old) received tail-vein injections of 5 3 10 6 T MBP-GFP , T P2-GFP or T OVA-GFP blasts (T blast cells). Alternatively, 2 3 10 6 (in 100 ml Eagle's Hepes (EH) medium) T blast cells were injected intratracheally into naïve animals previously anaesthetized and intubated. For transfer of migration-competent T MBP-GFP cells, 3 3 10 6 T migratory cells were isolated from the spleen 60 h after T-cell transfer and 1 3 10 6 from the lung 48 h after T-cell transfer and immediately transferred intravenously into recipient animals.
Active EAE was induced in naïve or memory animals by intratracheal or subcutaneous immunization.
For intratracheally induced EAE, 3 3 10 6 resting T MBP-GFP cells were intratracheally transferred into anaesthetized and intubated naïve animals. 3 h later the rats were immunized by intratracheal instillation of an emulsion (50 ml in PBS) containing CFA (20 ml per animal), MBP (1 mg ml 21 , 12.5 ml per animal) and China ink (1%). China ink could be detected both macroscopically and microscopically, confirming the correct intrapulmonary distribution of the antigen. The procedure was tolerated well. Note that administration of China ink alone, MBP in China ink, or OVA in CFA and China ink did not induce any clinical effect.
For subcutaneously induced active EAE, 1.5 3 10 6 T MBP-GFP cells were injected into the foot pad of naïve animals. 12 h later the animals were immunized by subcutaneous injection of an emulsion containing CFA (35 ml) and MBP (1 mg ml 21 , 35 ml). The same intratracheal or subcutaneous immunization protocols were applied to induce active EAE in memory animals.
The animals were observed daily for clinical symptoms. Their disease stage was scored as follows: 0, no disease; 1, flaccid tail; 2, gait impairments; 3, complete hind-limb paralysis; 4, tetraparesis; and 5, dead. Pre-activation of the BBB. BBB priming was induced by transfer of 5 3 10 6 nonlabelled T blast cells. Alternatively, 150 ng of LPS (25 ml of volume (LPS from Escherichia coli 0127:B8 Sigma-Aldrich)) were stereotactically injected into the cisterna magna of anaesthetized animals. Two-photon laser-scanning microscopy equipment. Two-photon laserscanning microscopy was carried out using a Zeiss Laser Scanning Microscope 710 combined with a Coherent Chameleon Vision II laser system. The excitation wavelength was set to 880 nm and the pulsed laser was routed through a Zeiss 320 water immersion objective (NA 0.95). Fluorescent signals were detected using non-descanned detectors equipped with 525/50-nm and 630/69-nm band-pass filters (Semrock). Surgical procedure and intravital imaging settings. Animals were anaesthetized using Ketamin (10%, Medistar) and Xylazin (Xylariem 20 mg, Riemser Arzneimittel) in equal proportions (100 ml per 100 g), tracheally intubated and ventilated with 1.5-2% isoflurane. A spinal cord imaging window was established at the level of Th12/L1 as previously described 6, 34 . Animals were stabilized in a custom-made microscope stage. Body temperature was controlled by a heated pad (37 uC) . Vital parameters were monitored during the imaging. Blood vessels were labelled by intravenous infusion of fluorescent dextran (Invitrogen). Acute slicing and imaging settings. Acute spinal-cord slices were prepared as reported 10 , with minor modifications. In brief, spinal cords were explanted and embedded in 7% low-melting agarose (Carl Roth GMBH). Acute slices (thickness of 300 mm) were prepared using a Vibrotome (Campden Vibroslicer).
Acute lung-slice preparation was adapted from a protocol described previously 35 . In brief, the lung was inflated with 2% low-melting agarose through the trachea. Subsequently, the lung was cut into pieces and embedded in 7% agarose gel. After hardening, slices of 1 mm in thickness were obtained using a Vibratome. Acute spinal-cord and lung slices were stored on ice in buffered cell medium and constantly oxygenized with carbogen until image acquisition. All the procedures were performed at 4 uC.
A custom-made heating chamber was supplied with humidified carbogen to visualize T-cell movement in acute slices of lung or spinal cord. Highresolution overview images were acquired using the Zeiss tile-scan module; time-lapse videos were acquired in 60-s intervals with approximately three spots imaged in parallel. Image analysis after intravital imaging. Three-dimensional reconstructions were generated using Imaris 7.1.1 (Bitplane). To determine T-cell velocity, fourdimensional data were generated by the Imaris Track module and revised manually. Motility parameters and trajectories were calculated from the obtained position coordinates using Excel (Microsoft). Crawling and rolling cells were defined as reported previously 2 .
Analysis of acute lung-slice overview images. Files were exported from the ZEN 2009 Software and analysed in ImageJ 1.45d (National Institutes of Health). Shading correction was carried out using Photoshop CS5 (Adobe Systems). For two-photon images with China-ink traces, a white-noise reduction was performed by removing signals present across all channels on a single-plane basis using ImageJ. For quantitative analysis, the green-channel image was enhanced by subtraction of autofluorescent, overlapping signals from the red and blue channels combined with noise reduction using ImageJ.
To quantify bronchiolar association of T cells in ImageJ, regions of transversally cut bronchiolar structures were subdivided into a peribronchial region (as determined by high collagen density) and a closely associated parenchymal region, defined as a 200-mm band surrounding, but not including, the peribronchial region. Mean pixel intensities (that is, the sum of all pixel values in the selection divided by the number of selected pixels) in these two regions were determined in the enhanced green-channel image and their ratio was defined as a measure for bronchiolar cell accumulation (bronchiolar association index). A non-parametric statistical analysis was performed (Dunn's multiple comparison test) using Graphpad 5.0.4 (GraphPad Software).
Overall cell counts per overview image were assessed by ImageJ's particle analyser after watershed segmentation of the enhanced green-channel image. Cell numbers from peribronchial accumulations were normalized to the relative frequency of bronchioles per analysed region to account for fluctuations in bronchiole density across multiple slices. Analysis of acute lung-slice time-lapse videos. Three-dimensional reconstructions were created as described above. If the blue channel signal from the timelapse data was too dim for high-quality three-dimensional reconstruction, high-resolution snap-shot acquisitions of the same area were overlaid on the time-lapse videos to provide a detailed view of the T-cell movement in the pulmonary environment. Fluorescence-microscopy equipment and imaging set-up. A Zeiss Axio Observer Fluorescence Microscope was used in combination with an HXP120C illuminator routed through a Zeiss Plan Apochromat 310 Air Objective. Fluorescent signals were detected using a Zeiss AxioCam HSM video camera. An atmosphere suitable for live imaging was generated by a Zeiss Heating Unit XL with constant carbogen gas supply. Glass-bottom wells (Greiner Bio-One) with custom-made compartments were used to acquire images from two treatment groups simultaneously. Multi-spot time-lapse videos were acquired with 200-ms image acquisition for the green (excitation: 470 nm, emission: 509 nm) and red (excitation: 558 nm, emission: 583 nm) channels and approximately 30-ms image acquisition for brightfield. Time-lapse image series were acquired (1-min intervals) with multiple spots in parallel. Analysis of time-lapse videos. All videos were analysed using Imaris 7.1.1. Cell trajectories were determined using the tracking module and revised manually. All 60-frame videos (1 min per frame, 60 min per video) were split into subsets of 10 frames for analysis. The relevant statistical data (for example, track speed) were RESEARCH LETTER exported to Microsoft Excel for further analysis. Cells that were visible in more than 3 of the 10 frames were included in the analysis. A cell was defined as motile if it moved more than 10 mm away from its origin during the 10-frame interval. For quantification of cell velocities, only motile cells were considered. Graphs were generated and statistical tests performed using Graphpad 5.0.4. Cell isolation, cytofluorometry and fluorescence-activated sorting. T MBP-GFP cells were isolated from spleen, blood, meninges and CNS parenchyma, as described previously 6, 8, 34 . From lymph nodes, T MBP-GFP cells were retrieved by sieved homogenization. Bone-marrow T MBP-GFP cells were isolated by flushing the cavity of the femur. To recover T MBP-GFP cells from lung, the organ was mechanically minced (McIlwain Tissue Chopper) and incubated with 0.3% collagenase (Sigma-Aldrich) for 1 h at 37 uC under constant shaking. Subsequently, the tissue was forced through a metal mesh and washed in EH medium. T cells were isolated by percoll gradient. Immediately after cell preparation, T GFP cells were sorted using a FACS Vantage or a FacsAria cell sorter (both by Becton Dickinson) or MoFlo (Beckman Coulter). All procedures were performed at 4 uC. Cytofluorometric analysis was carried out with a FACS-Calibur operated by Cell Quest software (Becton Dickinson). The number of T MBP-GFP cells was determined in relation to a known absolute number of added phycoerythrinlabelled beads (Becton Dickinson). For surface staining the following antibodies were used: CD4 (W3/25), CD8b, CD62L, abTCR (R73), Vb8.2 TCR, Vb8.5 TCR, Vb10 TCR, Vb16 TCR, Va4 TCR, Va8 TCR, CD45RA (OX33), CD11b (OX42), CD25 (OX39), CD134 (OX40), transferrin receptor (CD71), basigin (CD147), ItgB1(CD29) and neuropilin (Santa Cruz). Mouse immunoglobulinG1k (IgG1k) (MOPC-31 C, Sigma-Aldrich) served as isotype control. Allophycocyanin (APC)-labelled anti-mouse antibody (Dianova) was used as the secondary antibody. All antibodies were purchased from Serotec unless stated otherwise. Intracellular staining for IFN-c and IL-17 was carried out as described 6 . For intracellular staining of Ninj1, KLF2 and KLF4, samples were fixed in paraformaldehyde (PFA; 2%) for 20 min, permeabilized by Cytofix-Cytoperm buffer (Becton Dickinson) and then incubated with anti-Ninj1 monoclonal antibodies (MABs) (Becton Dickinson), anti-KLF2 (Chemicon international) and anti-KLF4 antibodies (Affinity Bioreagents) for 45 min. APC-labelled anti-mouse antibody and APC-labelled anti-rabbit antibody (both from Dianova) were used as secondary antibodies for Ninj1, and KLF2 and KLF4, respectively. In vivo proliferation and cell cycle analysis. 5-bromodeoxyuridine (BrdU) (120 mg kg 21 body weight; Becton Dickinson) was injected intraperitoneally 2 h before organ recovery. BrdU-containing T MBP-GFP cells were isolated from the single tissues and stained using a BrdU Flow kit (Becton Dickinson) according to the manufacturer's instructions. Cells were re-suspended in 7-amino-actinomycin D (7-AAD) solution just before flow-cytometry analyses. Cross-circulation model. Diethlyether anaesthesia followed by subcutaneous atropine (0.5 mg kg
21
) injection was induced in a naïve animal that was not pre-treated and in an animal that had received 5 3 10 6 T MBP-GFP cells 60 h beforehand (pre-EAE). Animals were then intubated and ventilated with 0.8% halothane in 70% N 2 O and 30% O 2 . A rectal probe was used to monitor body temperature. Body temperature was controlled by a heated pad (37 uC). The tail artery cannulation was used to measure the mean arterial blood pressure and for blood sampling at regular intervals to determine pH and arterial blood gases. A cannula was introduced into the tail artery in a proximal direction. Distal to the cannula, the artery was ligated and a second cannula was introduced in the distal direction of the tail artery. The two animals were connected through a heparinized catheter (Harvard Apparatus) from the proximal to the distal part and vice versa. A constant blood flow between the two animals was regularly monitored by injection of a small amount of NaCl. The arterial connection lasted 8 to 12 h. Thereafter, the animals were killed and the numbers of T MBP-GFP cells in the spleen and CNS of pre-EAE animals and animals that were not pre-treated were quantified by flow cytometry after the 12-h anastomosis. The efficiency of distributions across the blood shunt was measured in each experiment; as the 'transfer rates' substantially fluctuated between the different animal pairs (probably owing to variable blood flows within the shunts) relative numbers were given. Microarray analysis. Activated T cells (T MBP-GFP blast cells) were obtained 2 days post re-stimulation in vitro using thymocytes and MBP antigen followed by FACS sorting. Resting T cells (T MBP-GFP resting cells) were obtained 7 days post antigen exposure followed by FACS sorting. FACS sorting of spleen-derived migratory T cells (T MBP-GFP migratory cells) was performed 3 days post transfer. The sorting reached over 95% of purity. Transfer EAE was induced as described above. Cells were collected in cold PBS containing 1% rat serum, re-suspended in lysis buffer containing b-mercaptoethanol and mechanically broken up with a 23G needle. RNA was isolated from T MBP-GFP blast cells, T MBP-GFP resting cells and T MBP-GFP migratory cells using the Qiagen RNeasy mini kit. For every RNA sample, more than 10 3 10 6 cells were used. RNAs from four to six independent experiments with four animals in each experiment were combined into one RNA sample. Two RNA samples from spleen, five samples from T MBP-GFP blast cells and four from T MBP-GFP resting cells were analysed further. Integrity, size range and concentration of the RNAs were evaluated using the Agilent Bioanalyser (Agilent Technologies) and agarose gel electrophoresis. Total RNA was reverted into biotinylated cRNA according to the manufacturer's protocol (Affymetrix); the resultant cRNA was fragmented and then hybridized to the GeneChip Rat Genome 230Array (Affymetrix). The arrays were washed, stained and scanned by the GeneChip System confocal scanner (Hewlett Packard). Gene-expression profiles were background corrected and normalized on probe level using the variance stabilization method described previously 36 . Normalized probe intensities were summarized into gene-expression levels using the additive model as described 37 .
Comparison analysis was performed on the gene-expression data set pertaining to T MBP-GFP blast cells, T MBP-GFP resting cells and T MBP-GFP migratory cells, to obtain transcriptomes of activated state (T blast versus T resting ) and migratory state (T migratory versus T blast ). Transcriptomes were compared using Matlab. Average linkage hierarchical cluster analysis was performed on the annotated expression data set using Genesis 38 . Pathway-based analysis was carried out using GenMAPP 39 . For Gene-ontology based analysis, recent annotations for affymetrix probesets were downloaded from the Gene Ontology consortium database. Quantitative PCR. Total RNA was isolated using the standard Trizol method. cDNA was synthesized using Superscript III reverse transcriptase (Invitrogen). Quantitative PCR analysis was carried out using the 7500 Real Time PCR system (PE Applied Biosystems), as described 8, 34, 40 . b-actin was used as the house-keeping gene. Data were obtained by independent duplicate measurements. The CT value of the individual measurements did not exceed 0.5 amplification cycles. Several rat primers and probes were recently described . In brief, after the perfusion and postfixation steps, de-calcification was performed by incubating the total body in 14% EDTA for 2 weeks. Several tiles were assembled using the photomerge function in Adobe Photoshop CS5. Chemotactic assays. Directional migration of effector T cells was evaluated using 96-well trans-well plates (Corning Costar, 5-mm pore size) as described previously 40 . Briefly, 1 3 10 5 T GFP cells ex vivo isolated or obtained from in vitro culture were loaded in the upper chamber. CCL5 (0.1 ng ml
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